Community Acquired Pneumonia Flashcards

1
Q

Etiopathogenesis of Community-acquired-Pneumonia

A
  • Lower respiratory tract infetion acquired in the community within 24 hours or less than 2 weeks
  • Results from the proliferration of microbial pathogens at the alveolar level and the host’s response to those pathogens
  • Classic pneumonia (lobar pneumococcal pneumonia) evolves through a series of changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common access of microorganisms to the LRT

A

aspiration from the oropharynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phases of CAP

A
  • Edema
  • Red Hepatization
  • gray Heaptization
  • Resolution (final phase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Edema Phase of CAP

A
  • Initial phase with the presenc eof a proteinaceous exudtae, and often a bacteria in the alveoli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Red Hepatization

A
  • Presence of erythrocytes in the cellular intraalveolar exudate
  • Neutrophil influx is more important from the standpoimt of host defense
  • Bacteria are occasionally seen in pathologic specimens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gray Hepatization

A
  • No new erythrocytes are extravasating and those already have been lysed and degraded
  • The neutrophil is the predominant cell, fibrin deposition is abundant, and bacteria have disappeared
  • Corresponds with successful containment of the infection and improvement of gas exchange
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Resolution

A
  • macrophage reappears as the dominant cell type in the alveolar space, and the debris of neutrophils, bacteria, and fibrin has been cleared, as has the inflammatory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Manifrstations of CAP

A
  • commonly presents with acute cough, abnormal vital signs of tachypnea, tachycardia, and fever with at least one abnormal chest finding f diminished breath sounds, ronhi, crackles, or wheeze
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classification and Disposition of CAP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chest Xray for CAP

A
  • Essential in diagnosis of CAP, assessing severity, differentiating pneumonia from other conditions and in prognostication
  • Best radiologic evaluation cosists of standing posteroanterior and lateral views
  • Does not predict the likely etiologic agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sputum Gram Stain and Culture

A
  • Strongly indluenced by the quality of collection, transport, and processing
  • Main purpose of gram stain is to ensure that a sample is suitable for culture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adequate sputum sample

A
  • >25 neutrophils/LPF
  • <10 squamous epithelial cells/LPF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Blood culture for CAP

A
  • Yield is relatively low, therfore it is optional for hospitalized patients
  • Most common isolate: S. pneumoniae
  • Strongest indication for blood cultures: severe CAP (more likely be infected with S. aureus, P. aeruginosa, other gram negative bacilli)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Invasive procedures

A
  • transtracheal
  • Transthoracic biopsy
  • Bronchoalveolar lavage
  • Proteted brush specimen
  • Options for non-resolving pneumonia, immunocopmpromised patients, and in patients in whom no adequate respiratory specimens can be sent despite sputum induction androutine diagnostic testing
  • Most clear cut indication for extensive diagnostic testing is in the critically-ill CAP patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pneumonia Risk Score

A
  • CURB-65
  • Predicts mortality in CAP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Empiric Microbial Therapy for Low risk CAP

A
17
Q

Empiric Management Therapy for Moderate Risk CAP

A
18
Q

Empiric Treatment for igh Risk CAP

A
  • (Piperacillin-tazobactam IV or Cefepime IV or Meropenem IV) + Azithromycin IV + (Gentamicin IV) or Amikacin
  • (Piperacillin-tazobactam IV or Cefepime IV or Meropenem IV) + (ciprofloxacin IV or Levofloxacin IV)
19
Q

Common Antibiotics Used in CAP

A
20
Q

Duration of treatment for CAP

(most bacterial pneumonias)

A

5-7 days (3-5 for azalides for S. pneumoniae)

21
Q

Duration of treatment for CAP

(MSSA-CAP)

A

7-14 days (up to 21 days if bacteremic)

22
Q

Duration of treatment for CAP

(MRSA-CAP)

A

7-21 days (up to 28 days if bacteremic)

23
Q

Duration of treatment for CAP

(P. aeruginosa)

A

14-21 days (up to 28 days if bacteremic)

24
Q

Duration of treatment for CAP

(Mycoplsasma and Chlamydophila)

A

10-14 days

25
Q

Duration of treatment for CAP

(Legionella)

A

14-21 days (10 for azalides)

26
Q

Discharge criteria for CAP

A
  • during the 24 hours before discharge, the patient should have:
    • Temperature of 36-37.5 degrees celsius
    • Pulse <100/min
    • RR between 16-24/min
    • SBP >90 mmHg
    • Blood O2 saturation >90%
    • Functioning GI tract (allowing use of oral antibiotics)